1. Home
  2. RFM vs ASMB Comparison

RFM vs ASMB Comparison

Compare RFM & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFM
  • ASMB
  • Stock Information
  • Founded
  • RFM 2020
  • ASMB 2005
  • Country
  • RFM United States
  • ASMB United States
  • Employees
  • RFM N/A
  • ASMB N/A
  • Industry
  • RFM Finance/Investors Services
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • RFM Finance
  • ASMB Health Care
  • Exchange
  • RFM Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • RFM 92.3M
  • ASMB 92.1M
  • IPO Year
  • RFM N/A
  • ASMB 2010
  • Fundamental
  • Price
  • RFM $15.61
  • ASMB $13.42
  • Analyst Decision
  • RFM
  • ASMB Buy
  • Analyst Count
  • RFM 0
  • ASMB 2
  • Target Price
  • RFM N/A
  • ASMB $35.00
  • AVG Volume (30 Days)
  • RFM 20.7K
  • ASMB 22.9K
  • Earning Date
  • RFM 01-01-0001
  • ASMB 03-27-2025
  • Dividend Yield
  • RFM 9.74%
  • ASMB N/A
  • EPS Growth
  • RFM N/A
  • ASMB N/A
  • EPS
  • RFM N/A
  • ASMB N/A
  • Revenue
  • RFM N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • RFM N/A
  • ASMB $282.16
  • Revenue Next Year
  • RFM N/A
  • ASMB N/A
  • P/E Ratio
  • RFM N/A
  • ASMB N/A
  • Revenue Growth
  • RFM N/A
  • ASMB N/A
  • 52 Week Low
  • RFM $12.89
  • ASMB $11.01
  • 52 Week High
  • RFM $16.41
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • RFM 65.66
  • ASMB 40.25
  • Support Level
  • RFM $15.24
  • ASMB $13.60
  • Resistance Level
  • RFM $15.60
  • ASMB $14.25
  • Average True Range (ATR)
  • RFM 0.07
  • ASMB 0.58
  • MACD
  • RFM 0.05
  • ASMB -0.05
  • Stochastic Oscillator
  • RFM 99.98
  • ASMB 5.93

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: